Zhang, Z.; Liang, S.; Zheng, D.; Wang, S.; Zhou, J.; Wang, Z.; Huang, Y.; Chang, C.; Wang, Y.; Guo, Y.;
et al. Using Cancer-Associated Fibroblasts as a Shear-Wave Elastography Imaging Biomarker to Predict Anti-PD-1 Efficacy of Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2025, 26, 3525.
https://doi.org/10.3390/ijms26083525
AMA Style
Zhang Z, Liang S, Zheng D, Wang S, Zhou J, Wang Z, Huang Y, Chang C, Wang Y, Guo Y,
et al. Using Cancer-Associated Fibroblasts as a Shear-Wave Elastography Imaging Biomarker to Predict Anti-PD-1 Efficacy of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2025; 26(8):3525.
https://doi.org/10.3390/ijms26083525
Chicago/Turabian Style
Zhang, Zhiming, Shuyu Liang, Dongdong Zheng, Shiyu Wang, Jin Zhou, Ziqi Wang, Yunxia Huang, Cai Chang, Yuanyuan Wang, Yi Guo,
and et al. 2025. "Using Cancer-Associated Fibroblasts as a Shear-Wave Elastography Imaging Biomarker to Predict Anti-PD-1 Efficacy of Triple-Negative Breast Cancer" International Journal of Molecular Sciences 26, no. 8: 3525.
https://doi.org/10.3390/ijms26083525
APA Style
Zhang, Z., Liang, S., Zheng, D., Wang, S., Zhou, J., Wang, Z., Huang, Y., Chang, C., Wang, Y., Guo, Y., & Zhou, S.
(2025). Using Cancer-Associated Fibroblasts as a Shear-Wave Elastography Imaging Biomarker to Predict Anti-PD-1 Efficacy of Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 26(8), 3525.
https://doi.org/10.3390/ijms26083525
